4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000006
PRESIDENT AND COO sold 22,500 shares at an average $450.24 ($10,130,439)
- PRESIDENT AND COO acquired 22,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENKOWITZ MICHAEL · PRESIDENT AND COO
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,625 | $135.42 | $1,980,518 | 14,625 | I |
| 2025-10-06 | Sale : show line 2 in the form 10b5-1 | −400 | $449.82 | $179,928 | 14,225 | I |
| 2025-10-06 | Sale : show line 3 in the form 10b5-1 | −800 | $450.97 | $360,777 | 13,425 | I |
| 2025-10-06 | Sale : show line 4 in the form 10b5-1 | −11,975 | $452.03 | $5,413,011 | 1,450 | I |
| 2025-10-06 | Sale : show line 5 in the form 10b5-1 | −1,250 | $453.16 | $566,449 | 200 | I |
| 2025-10-06 | Sale : show line 6 in the form 10b5-1 | −200 | $253.98 | $50,795 | 0 | I |
| 2025-10-06 | Exercise or conversion : show line 7 in the form 10b5-1 | +7,875 | $146.03 | $1,149,986 | 7,875 | I |
| 2025-10-06 | Sale : show line 8 in the form 10b5-1 | −300 | $450.06 | $135,017 | 7,575 | I |
| Open-market sales · 22,500 sh · avg $450.24 · $10,130,439 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-10-06 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Options | −14,625 | $135.42 | 2027-03-15 | 14,325 | 99,750 | I |
| 2025-10-06 | Exercise or conversion : show line 14 in the form 10b5-1 Stock Options | −7,875 | $146.03 | 2027-03-15 | 7,875 | 17,500 | I |
Loading xslF345X05/primarydocument.xml…